INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 27 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $253,000 | – | 1,125,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 184,667 | $279,000 | 0.62% |
| IMS Capital Management | 29,536 | $35,000 | 0.03% |
| Paulson Wealth Management Inc. | 11,250 | $4,000 | 0.00% |
| Next Capital Management LLC | 1,139 | $2,000 | 0.00% |
| Renaissance Technologies | 362,282 | $547,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,972 | $39,000 | 0.00% |
| UBS Group AG | 79 | $0 | 0.00% |
| IFP Advisors, Inc | 3 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $2,000 | 0.00% |
| Advisor Group, Inc. | 963 | $1,000 | 0.00% |